Literature DB >> 9306341

A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease.

L Longa1, F Scolari, A Brusco, C Carbonara, S Polidoro, B Valzorio, P Riegler, N Migone, R Maiorca.   

Abstract

BACKGROUND: The renal lesions in tuberous sclerosis complex (TSC) consist in multiple angiomyolipomas, often associated with cysts of variable size. Recently a few TSC patients with early-onset renal cysts resembling the autosomal dominant polycystic kidney disease (ADPKD) have been described. Virtually all of them showed deletions of both TSC2 and PKD1 genes.
METHODS: Two unrelated families in which TSC and PKD co-segregate were investigate. 16p13.3-linked haplotype segregation, Southern blot, pulsed field gel electrophoresis, and loss of heterozygosity analyses were performed in both affected and unaffected family members.
RESULTS: The proband from family 1 was first recognized as presenting typical neurological signs and skin lesions of TSC and multiple renal cysts at 12 years of age. Haemodialysis became necessary at age 28. CT and MRI scans revealed multiple cysts in the live and an asymptomatic, 3-4 mm aneurysm of the middle cerebral artery. His mother, who died at 47 of breast cancer, had ADPKD and reached the ESRD at 42. She showed facial angiofibromas. Both patients carried a submicroscopic germline deletion spanning the entire TSC2 gene and the large majority of PKD1 coding sequence. In the proband from family 2, the TSC diagnosis was made at 4 years. Enlarged polycystic kidneys causing and-stage renal failure at 19 years were observed. This patient carried a large germline, de novo deletion involving the entire TSC2 and PKD1 genes. In addition we could show in a renal hamartoma from this subject the loss of heterozygosity of markers spanning the TSC2 and PKD1 genes from the residual, normal chromosome 16 of paternal origin.
CONCLUSIONS: The presence of a deletion involving both TSC2 and PKD1 genes should be considered in the clinical assessment of TSC children with an early-onset polycystic kidney disease, and more generally in all ADPKD patients who develop end-stage renal failure prior to the fourth or fifth decade of life. Finally, the occurrence of typical renal and extrarenal signs of ADPKD in a PKD1 hemizygote individual seems to support concept that a somatic inactivation of the residual PKD1 gene is required for the development of the cysts.

Entities:  

Mesh:

Year:  1997        PMID: 9306341     DOI: 10.1093/ndt/12.9.1900

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

Review 1.  Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

Authors:  A C Jones; M M Shyamsundar; M W Thomas; J Maynard; S Idziaszczyk; S Tomkins; J R Sampson; J P Cheadle
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

Review 2.  Novel therapeutic approaches to autosomal dominant polycystic kidney disease.

Authors:  Wells B LaRiviere; Maria V Irazabal; Vicente E Torres
Journal:  Transl Res       Date:  2014-11-13       Impact factor: 7.012

3.  Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.

Authors:  Susan J Back; Savvas Andronikou; Tracy Kilborn; Bernard S Kaplan; Kassa Darge
Journal:  Pediatr Radiol       Date:  2014-10-30

4.  Tuberous sclerosis complex with an unruptured intracranial aneurysm: manifestations of contiguous gene syndrome.

Authors:  Y L Chen; C B Luo; S W Hsu; G Rodesch; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2002-01-10       Impact factor: 1.610

5.  Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.

Authors:  Mark B Consugar; Wai C Wong; Patrick A Lundquist; Sandro Rossetti; Vickie J Kubly; Denise L Walker; Laureano J Rangel; Richard Aspinwall; W Patrick Niaudet; Seza Ozen; Albert David; Milen Velinov; Eric J Bergstralh; Kyongtae T Bae; Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Julian R Sampson; Brian D Dawson; Peter C Harris
Journal:  Kidney Int       Date:  2008-09-24       Impact factor: 10.612

6.  Dyspnea in a 43-year-old woman with polycystic kidney disease.

Authors:  Howard Y Li; Gregory P Cosgrove; Jeffrey J Swigris
Journal:  Chest       Date:  2009-01       Impact factor: 9.410

7.  Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development.

Authors:  Shengli Cai; Jeffrey I Everitt; Hiroyuki Kugo; Jennifer Cook; Elena Kleymenova; Cheryl Lyn Walker
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 8.  Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.

Authors:  Emmett V Schmidt; Michael J Ravitz; Li Chen; Mary Lynch
Journal:  Cell Cycle       Date:  2009-05-18       Impact factor: 4.534

Review 9.  A Review of the Genetics of Intracranial Berry Aneurysms and Implications for Genetic Counseling.

Authors:  Emma Hitchcock; William T Gibson
Journal:  J Genet Couns       Date:  2016-10-14       Impact factor: 2.537

10.  The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.

Authors:  Tiffiney R Hartman; Dongyan Liu; Jack T Zilfou; Victoria Robb; Tasha Morrison; Terry Watnick; Elizabeth P Henske
Journal:  Hum Mol Genet       Date:  2008-10-09       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.